ResearcherKyoto UniversityActive in the last 2 years

Hirotaka Kashima

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0003-1701-9672; OpenAlex author ID A5031040638. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 12

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

Comparison of Comprehensive Serum miRNA Sequencing and Apolipoprotein A2 Isoforms for Early Detection of Pancreatic Cancer. Co-author DOI 10.3390/cancers18071177 ↗
[A case of thrombotic microangiopathy during chemotherapy with gemcitabine in a patient with pancreatic cancer]. Co-author DOI 10.11405/nisshoshi.119.259 ↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Kosuke Minaga · 1 shared paper, 2026 · strength 0.21
- Paper Comparison of Comprehensive Serum miRNA Sequencing and Apolipoprotein A2 Isoforms for Early Detection of Pancreatic Can… DOI 10.3390/cancers18071177 ↗
Munenori Kawai · 1 shared paper, 2026 · strength 0.21
- Paper Comparison of Comprehensive Serum miRNA Sequencing and Apolipoprotein A2 Isoforms for Early Detection of Pancreatic Can… DOI 10.3390/cancers18071177 ↗
Toshihiro Morita · 1 shared paper, 2026 · strength 0.21
- Paper Comparison of Comprehensive Serum miRNA Sequencing and Apolipoprotein A2 Isoforms for Early Detection of Pancreatic Can… DOI 10.3390/cancers18071177 ↗
Atsushi Umemura · 1 shared paper, 2026 · strength 0.21
- Paper Comparison of Comprehensive Serum miRNA Sequencing and Apolipoprotein A2 Isoforms for Early Detection of Pancreatic Can… DOI 10.3390/cancers18071177 ↗
Hiroshi Seno · 1 shared paper, 2026 · strength 0.21
- Paper Comparison of Comprehensive Serum miRNA Sequencing and Apolipoprotein A2 Isoforms for Early Detection of Pancreatic Can… DOI 10.3390/cancers18071177 ↗
Kazuyuki Nagai · 1 shared paper, 2026 · strength 0.21
- Paper Comparison of Comprehensive Serum miRNA Sequencing and Apolipoprotein A2 Isoforms for Early Detection of Pancreatic Can… DOI 10.3390/cancers18071177 ↗
Etsuro Hatano · 1 shared paper, 2026 · strength 0.21
- Paper Comparison of Comprehensive Serum miRNA Sequencing and Apolipoprotein A2 Isoforms for Early Detection of Pancreatic Can… DOI 10.3390/cancers18071177 ↗
Kei Iimori · 1 shared paper, 2026 · strength 0.21
- Paper Comparison of Comprehensive Serum miRNA Sequencing and Apolipoprotein A2 Isoforms for Early Detection of Pancreatic Can… DOI 10.3390/cancers18071177 ↗
Shujiro Yazumi · 1 shared paper, 2026 · strength 0.21
- Paper Comparison of Comprehensive Serum miRNA Sequencing and Apolipoprotein A2 Isoforms for Early Detection of Pancreatic Can… DOI 10.3390/cancers18071177 ↗
Akihisa Fukuda · 1 shared paper, 2026 · strength 0.21
- Paper Comparison of Comprehensive Serum miRNA Sequencing and Apolipoprotein A2 Isoforms for Early Detection of Pancreatic Can… DOI 10.3390/cancers18071177 ↗
Yuto Kimura · 1 shared paper, 2022 · strength 0.15
- Paper [A case of thrombotic microangiopathy during chemotherapy with gemcitabine in a patient with pancreatic cancer]. DOI 10.11405/nisshoshi.119.259 ↗
Masaya Ohana · 1 shared paper, 2022 · strength 0.15
- Paper [A case of thrombotic microangiopathy during chemotherapy with gemcitabine in a patient with pancreatic cancer]. DOI 10.11405/nisshoshi.119.259 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.